- Home
- NBTX vs ATLC Comparison
NBTX vs ATLC Comparison
Compare NBTX & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBTX | ATLC |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 816.9M |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | NBTX | ATLC |
|---|---|---|
| Price | $22.91 | $66.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $8.00 | ★ $87.50 |
| AVG Volume (30 Days) | 50.1K | ★ 82.4K |
| Earning Date | 09-30-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.57 |
| EPS | N/A | ★ 5.63 |
| Revenue | $11,930,711.00 | ★ $498,496,000.00 |
| Revenue This Year | N/A | $403.57 |
| Revenue Next Year | $136.64 | $60.82 |
| P/E Ratio | ★ N/A | $11.71 |
| Revenue Growth | N/A | ★ 33.26 |
| 52 Week Low | $2.82 | $41.37 |
| 52 Week High | $30.35 | $78.91 |
Technical Indicators
Market Signals| Indicator | NBTX | ATLC |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 68.45 |
| Support Level | $20.83 | $58.08 |
| Resistance Level | $23.77 | $68.99 |
| Average True Range (ATR) | 0.88 | 2.39 |
| MACD | 0.17 | 1.13 |
| Stochastic Oscillator | 77.16 | 80.72 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About ATLC Atlanticus Holdings Corporation
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.